Cargando…

B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma

BACKGROUND: Invasive adenocarcinoma (IAC), which is typically preceded by minimally invasive adenocarcinoma (MIA), is the dominant pathological subtype of early-stage lung adenocarcinoma (LUAD). Identifying the molecular events underlying the progression from MIA to IAC may provide a crucial perspec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yanan, Li, Jun, Zhang, Pengpeng, Yin, Dandan, Wang, Ziyu, Dai, Jiali, Wang, Wei, Zhang, Erbao, Guo, Renhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259029/ https://www.ncbi.nlm.nih.gov/pubmed/37303063 http://dx.doi.org/10.1186/s13046-023-02711-3

Ejemplares similares

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer
por: Dai, Jiali, et al.
Publicado: (2023)

Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis
por: Dai, Jiali, et al.
Publicado: (2023)

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
por: Chen, Nan, et al.
Publicado: (2017)

C1GALT1 in health and disease
por: Sun, Xiaojie, et al.
Publicado: (2021)

Update on the role of C1GALT1 in cancer
por: Xia, Tong, et al.
Publicado: (2022)

C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy
por: Xing, Yue, et al.
Publicado: (2020)

Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway
por: Jin, Guilin, et al.
Publicado: (2023)

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
por: Jiang, Xianjie, et al.
Publicado: (2019)

Structural basis for the synthesis of the core 1 structure by C1GalT1
por: González-Ramírez, Andrés Manuel, et al.
Publicado: (2022)

Expression and Impact of C1GalT1 in Cancer Development and Progression
por: Wan, Yangu, et al.
Publicado: (2021)

Two Hydroxyproline Galactosyltransferases, GALT5 and GALT2, Function in Arabinogalactan-Protein Glycosylation, Growth and Development in Arabidopsis
por: Basu, Debarati, et al.
Publicado: (2015)

c‐Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR‐145‐5p/SPOP/PD‐L1 axis
por: Zhang, Lan, et al.
Publicado: (2021)

B4GalT1 Regulates Apoptosis and Autophagy of Glioblastoma In Vitro and In Vivo
por: Wang, Pu, et al.
Publicado: (2020)

PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1
por: Ma, Yihui, et al.
Publicado: (2021)

Clinical importance of VEGFC and PD‐L1 co‐expression in lung adenocarcinoma patients
por: Qin, Tingting, et al.
Publicado: (2020)

S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression: S100a9 deficiency accelerates tumor escape
por: Wang, Roujia, et al.
Publicado: (2023)

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2021)

Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling
por: Zhu, Ping, et al.
Publicado: (2022)

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021)

A novel mechanism for C1GALT1 in the regulation of gastric cancer progression
por: Dong, Xiaoxia, et al.
Publicado: (2021)

MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3
por: Shao, Lijuan, et al.
Publicado: (2021)

Germline C1GALT1C1 mutation causes a multisystem chaperonopathy
por: Erger, Florian, et al.
Publicado: (2023)

In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression
por: Montero-Calle, Ana, et al.
Publicado: (2023)

Selective Generation of Gut Tropic T Cells in Gut-associated Lymphoid Tissue (GALT): Requirement for GALT Dendritic Cells and Adjuvant
por: Johansson-Lindbom, Bengt, et al.
Publicado: (2003)

PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
por: Cretella, Daniele, et al.
Publicado: (2019)

PB1919: S100A9 DEFICIENCY ACCELERATES MDS ASSOCIATED TUMOR ESCAPE VIA PD-1/PD-L1 OVEREXPRESSION
por: Wang, R., et al.
Publicado: (2022)

High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia
por: Ren, Zhihong, et al.
Publicado: (2022)

The dimeric structure of wild-type human glycosyltransferase B4GalT1
por: Harrus, Deborah, et al.
Publicado: (2018)

B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis
por: De Vitis, Claudia, et al.
Publicado: (2022)

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021)

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
por: Peng, Shunli, et al.
Publicado: (2019)

Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
por: Ma, Ke, et al.
Publicado: (2020)

Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203
por: Wang, Liang, et al.
Publicado: (2018)

C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma
por: Dong, Xiaoxia, et al.
Publicado: (2021)

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
por: Zhang, Hao, et al.
Publicado: (2021)

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients
por: Xie, Huyang, et al.
Publicado: (2018)

C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α(v)
por: Kuo, Ting-Chun, et al.
Publicado: (2021)

LncRNA SNHG15 Contributes to Immuno-Escape of Gastric Cancer Through Targeting miR141/PD-L1
por: Dang, Shengchun, et al.
Publicado: (2020)

Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations
por: van den Boogert, Marjolein A.W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l1q00knkob19ll11s2h14gsk63